LENZ Therapeutics Ratios (2022-2025) | LENZ

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter) -288.24%-133.60%-2,260.33%
EBIT Margin (Quarter) -337.14%-151.10%-2,422.10%
EBITDA Margin (Quarter) -299.94%-132.09%-2,259.51%
Operating Margin (Quarter) -337.14%-151.10%-2,422.10%
Net Margin (Quarter) -298.24%-133.60%-2,260.45%
FCF Margin (Quarter) -234.96%-72.22%-2,082.05%
Efficiency
Inventory Average (Quarter) 1.68M2.07M2.48M2.27M1.05M1.94M
Assets Average (Quarter) 366.20M344.32M328.37M315.95M298.52M276.64M241.78M209.98M213.32M219.66M208.28M209.29M214.02M258.29M
Equity Average (Quarter) 349.88M327.45M146.14M-30.42M-43.94M-60.39M64.30M195.54M204.10M209.68M198.05M199.19M200.15M239.13M
Invested Capital (Quarter) 361.30M338.46M316.45M-24.17M-36.68M-51.21M-69.57M198.17M192.92M215.28M204.08M192.01M206.37M193.93M284.34M
Asset Utilization Ratio (Quarter) 0.020.080.07
Leverage & Solvency
Equity Ratio (Quarter) 0.950.960.95-0.08-0.12-0.18-0.260.910.950.960.950.950.950.920.93
Valuation
Enterprise Value (Quarter) -339.18M-322.29M-291.69M-268.23M-202.25M-246.66M-233.99M-200.47M-196.11M-41.15M-209.03M-23.16M-37.72M-25.40M-292.35M
Return Ratios
Return on Sales (Quarter) -2.98%-1.34%-22.60%
Return on Capital Employed (Quarter) -0.34%-0.31%-0.28%-0.28%-0.29%-0.32%-0.31%-0.28%-0.30%-0.31%-0.34%-0.38%
Return on Invested Capital (Quarter) -0.31%-0.34%-0.38%
Return on Assets (Quarter) -0.32%-0.29%-0.27%-0.26%-0.25%-0.28%-0.26%-0.22%-0.23%-0.25%-0.28%-0.32%
Return on Equity (Quarter) -0.72%3.03%1.83%1.21%-0.95%-0.30%-0.27%-0.23%-0.24%-0.26%-0.29%-0.34%